Genmab A (GMAB) Payables: 2018-2020
- Genmab A's Payables rose 57.13% to $35,770 in Q4 2020 from the same period last year, while for Dec 2020 it was $31.3 billion, marking a year-over-year change of. This contributed to the annual value of $35,770 for FY2020, which is 57.13% up from last year.
- Per Genmab A's latest filing, its Payables stood at $35,770 for Q4 2020, which was down 100.00% from $8.1 billion recorded in Q2 2020.
- Genmab A's Payables' 5-year high stood at $23.2 billion during Q2 2019, with a 5-year trough of $22,765 in Q4 2019.
- Over the past 3 years, Genmab A's median Payables value was $8.1 billion (recorded in 2020), while the average stood at $10.0 billion.
- Per our database at Business Quant, Genmab A's Payables tumbled by 100.00% in 2019 and then surged by 57.13% in 2020.
- Quarterly analysis of 3 years shows Genmab A's Payables stood at $18.6 billion in 2018, then tumbled by 100.00% to $22,765 in 2019, then skyrocketed by 57.13% to $35,770 in 2020.
- Its last three reported values are $35,770 in Q4 2020, $8.1 billion for Q2 2020, and $22,765 during Q4 2019.
